Minor refinements to the device post cohort 2 and further practice in its delivery has meant that our previous outstanding results have incredibly been improved in cohort 3.
This is fantastic.
Ann: DurAVR Maintains Exceptional Results in New Patient Cohort, page-2
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.00 |
Change
0.000(0.00%) |
Mkt cap ! $317.0M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.00 | $14.36 | $82.01K | 5.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $14.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 5141 | 3 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |